Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WDR5 | P61964 | 1/20 | 0.50 |
| ▸ | PNP | P00491 | 1/20 | 0.45 |
| ▸ | DCAF1 | Q9Y4B6 | 2/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.42 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.42 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CTSA | P10619 | 1/20 | 0.40 |
| ▸ | TACR3 | P29371 | 1/20 | 0.39 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.39 |
| ▸ | OGG1 | O15527 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6667661 | 0.87 | FFAR1 (0.46) | WDR5DCAF1MEN1KMT2ACTSA | |
| SCHEMBL24036755 | 0.87 | L3MBTL1 (0.42) | WDR5PNPHPGDMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL7177344 | 0.86 | FFAR1 (0.45) | CTSAAOC3 | |
| SCHEMBL12824986 | 0.86 | HPGD (0.49) | DCAF1HPGDMEN1KMT2AALDH1A1 | |
| SCHEMBL12826083 | 0.86 | HPGD (0.49) | DCAF1HPGDMEN1KMT2AALDH1A1 | |
| SCHEMBL24036950 | 0.85 | TACR3 (0.39) | WDR5MEN1KMT2ATACR3 | |
| SCHEMBL24036727 | 0.85 | KCNA5 (0.47) | WDR5MEN1KMT2AALDH1A1TACR3 | |
| SCHEMBL24036947 | 0.82 | L3MBTL1 (0.40) | MEN1KMT2ATACR3 | |
| SCHEMBL24036565 | 0.82 | WDR5 (0.37) | WDR5PNPHPGDMEN1KMT2A | |
| SCHEMBL25754075 | 0.82 | WDR5 (0.37) | WDR5PNPMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192661-A1 | 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE | UBE CORPORATION (JP) | 2023-06-22 | — | — | US | disclosed |
| WO-2021230325-A1 | 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE | 宇部興産株式会社 | 2021-11-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192661-A1 | 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE | DHFR, DPYD, CYP2D6 | WDR5 2145/4885PNP 189/4885DCAF1 3357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.